GIP
PRCT icon

Granite Investment Partners’s Procept Biorobotics PRCT Stock Holding History

Granite Investment Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Buy
253,358
+1,330
+0.5% +$33.3K 0.29% 106
2026
Q1 		$6.3M Sell
252,028
-13,605
-5% -$383K 0.39% 92
2025
Q4 		$8.36M Buy
265,633
+190,775
+255% +$6.33M 0.5% 74
2025
Q3 		$2.67M Sell
74,858
-66,784
-47% -$3.05M 0.15% 142
2025
Q2 		$8.16M Buy
+141,642
New +$8.01M 0.4% 85

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Granite Investment Partners's PRCT Position: Q2 2026 in Review

Granite Investment Partners increased its Procept Biorobotics (PRCT) stake by 0.53% in Q2 2026, buying an estimated $33.3K and bringing the position to 253,358 shares worth $5.72M. The position accounts for 0.29% of the portfolio, ranked #106.

Granite Investment Partners first reported a position in PRCT in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.36M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Granite Investment Partners held 253,358 shares of Procept Biorobotics worth $5.72M as of Q2 2026.
  • Granite Investment Partners bought 1,330 Procept Biorobotics shares in Q2 2026, an estimated $33.3K.
  • Procept Biorobotics made up 0.29% of Granite Investment Partners's portfolio in Q2 2026, its #106 holding.
  • Granite Investment Partners first reported a position in Procept Biorobotics in Q2 2025 and has held it in 5 quarters since.
  • Granite Investment Partners's Procept Biorobotics position peaked at $8.36M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Granite Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.